Early Rhythm Control Therapy - the EAST-AFNET 4 Trial

 

Dr. Tom Tadros an Electrophysiologist from Harvard Medical School - The Brigham & Women’s Hospital discusses the landmark EAST-AFNET 4 study which highlights the importance of early-rhythm control therapy in patients with atrial fibrillation.

 
Previous
Previous

Heart Failure and Atrial Fibrillation

Next
Next

Arrhythmia 101: Ventricular Tachycardia